Bailard Inc. Makes New Investment in National Health Investors, Inc. (NYSE:NHI)

Bailard Inc. bought a new position in National Health Investors, Inc. (NYSE:NHI - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 9,875 shares of the real estate investment trust's stock, valued at approximately $729,000.

Other large investors have also made changes to their positions in the company. Loomis Sayles & Co. L P boosted its stake in National Health Investors by 42.0% in the fourth quarter. Loomis Sayles & Co. L P now owns 639 shares of the real estate investment trust's stock valued at $44,000 after acquiring an additional 189 shares during the period. GF Fund Management CO. LTD. acquired a new position in National Health Investors in the fourth quarter valued at approximately $58,000. Farther Finance Advisors LLC boosted its stake in National Health Investors by 5,000.0% in the first quarter. Farther Finance Advisors LLC now owns 918 shares of the real estate investment trust's stock valued at $68,000 after acquiring an additional 900 shares during the period. NewEdge Advisors LLC bought a new stake in shares of National Health Investors during the fourth quarter valued at approximately $83,000. Finally, Xponance Inc. raised its holdings in shares of National Health Investors by 9.5% during the fourth quarter. Xponance Inc. now owns 2,997 shares of the real estate investment trust's stock valued at $208,000 after buying an additional 259 shares during the last quarter. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Stock Up 0.4%

NHI stock traded up $0.28 during midday trading on Friday, hitting $70.50. The company's stock had a trading volume of 237,993 shares, compared to its average volume of 253,472. The company has a debt-to-equity ratio of 0.88, a current ratio of 16.55 and a quick ratio of 16.55. National Health Investors, Inc. has a twelve month low of $65.13 and a twelve month high of $86.13. The company's fifty day moving average price is $71.82 and its 200 day moving average price is $71.70. The stock has a market capitalization of $3.29 billion, a P/E ratio of 22.38, a PEG ratio of 3.55 and a beta of 0.73.

National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $1.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.13 by $0.02. The firm had revenue of $68.87 million during the quarter, compared to the consensus estimate of $85.13 million. National Health Investors had a net margin of 41.15% and a return on equity of 10.64%. The business's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.10 EPS. As a group, equities research analysts predict that National Health Investors, Inc. will post 4.41 EPS for the current year.

National Health Investors Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 1st. Shareholders of record on Monday, June 30th will be given a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 5.11%. The ex-dividend date of this dividend is Monday, June 30th. National Health Investors's dividend payout ratio (DPR) is currently 114.29%.

Wall Street Analyst Weigh In

Several research analysts have issued reports on NHI shares. KeyCorp raised National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 price target on the stock in a report on Thursday, July 10th. Wedbush raised National Health Investors to a "strong-buy" rating in a report on Wednesday, July 2nd. Finally, Truist Financial upgraded shares of National Health Investors from a "hold" rating to a "buy" rating and set a $77.00 price objective on the stock in a research report on Wednesday, July 2nd. Two equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $84.60.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.